Social Media

A pioneering cancer treatment has been recommended for leukaemia patients under the age of 25.CART-cell therapy involves taking a person's own immune cells and modifying them to fight their cancer cells, and has the potential to be a cure.The National Institute for Health and Care Excellence (Nice) said young people…
The mother of a girl with cystic fibrosis is taking legal action against the NHS after it refused funding for a drug which could extend her daughter's life.Sarah Burgwin, of Totnes, Devon, said it was "shameful" that six-year-old Katie Stafford (both pictured) was being denied access to Orkambi.The drug's high…
The decision not to make a drug which slows the effects of multiple sclerosis (MS) available on the NHS is "deeply disappointing", a charity has said as it launched a petition against the move. The National Institute for Health and Care Excellence (Nice) announced on Monday that it was not…
The removal of financial incentives for GPs has been linked with a decline in performance by a new study. Researchers said an "immediate" reduction recorded across 12 quality measures they studied may be partly accounted for by changes to doctors' methods of documentation. However, they said declines in measures involving…
Children and young people with a form of leukaemia will have access to a groundbreaking treatment after NHS England secured a deal with the drug manufacturer. Tisagenlecleucel, a form of chimeric antigen receptor T-Cell (CAR-T) therapy, has been shown to cure some patients with B cell acute lymphoblastic leukaemia. NHS…
A "new generation" cancer therapy has been rejected for widespread NHS use by health officials. The National Institute for Health and Care Excellence (Nice) published draft guidance stating that axicabtagene ciloleucel, also known as Yescarta, is not recommended for NHS use for patients with aggressive sub-types of non-Hodgkin lymphoma. The…
A weight-loss pill has been hailed as a potential "holy grail" in the fight against obesity after a major study showed it did not increase the risk of serious heart problems. Researchers say lorcaserin is the first weight-loss drug to be deemed safe for heart health with long-term use, which…
Health workers should help people with sexually transmitted infections notify their partners about their condition, according to new official guidance. Helping people diagnosed with sexually transmitted infections (STI) inform their partners may stem the spread of infection, according to a new draft quality standard by the National Institute for Health…
People at a higher risk during the flu season should be able to get their flu jab in the evenings and at weekends to encourage uptake of the vaccine, new guidance suggests. Suggestions on how to help increase vaccination rates includes those who offer free NHS flu jabs - such…
An eight-year-old boy with cystic fibrosis has urged a pharmaceutical company to lower the price of a drug so it can be made available on the NHS. Orkambi received its European licence exactly 1,000 days ago, but the National Institute of Care and Excellence (Nice) has not recommended it for…
A charity has condemned a decision by health officials to reject a drug to treat a rare genetic disorder which can mean that affected children do not live to their their second birthday. In new draft guidance, the National Institute for Health and Care Excellence (Nice) has not recommended Spinraza,…
A drug that slows the affects of multiple sclerosis (MS) has been recommended for treatment on the NHS. The National Institute for Health and Care Excellence (Nice) has published draft guidance which recommends ocrelizumab for treating relapsing-remitting MS in adults. There are around 100,000 people with MS in the UK,…
Page 1 of 4